Contrast Enhanced MRI in the Diagnosis of HCC
Hepatocellular carcinoma (HCC) is the 6th most common cancer worldwide. Imaging plays a critical role in HCC screening and diagnosis. Initial screening of patients at risk for HCC is performed with ultrasound. Confirmation of HCC can then be obtained by Computed Tomography (CT) or Magnetic Resonance...
Main Authors: | Eric Niendorf, Benjamin Spilseth, Xiao Wang, Andrew Taylor |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-09-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | http://www.mdpi.com/2075-4418/5/3/383 |
Similar Items
-
HCC screening: assessment of an abbreviated non-contrast MRI protocol
by: Michael Vinchill Chan, et al.
Published: (2019-12-01) -
Diagnostic Performance of Simulated Abbreviated MRI for Early-Stage Hepatocellular Carcinoma Screening: A Comparison to Conventional Dynamic Contrast-Enhanced MRI
by: Eun Sol Lim, et al.
Published: (2021-09-01) -
Abbreviated MRI Protocol for the Assessment of Ablated Area in HCC Patients
by: Vincenza Granata, et al.
Published: (2021-03-01) -
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
by: Bang-Bin Chen, et al.
Published: (2021-07-01) -
A preoperative model for predicting microvascular invasion and assisting in prognostic stratification in liver transplantation for HCC regarding empirical criteria
by: Wenhui Zhang, et al.
Published: (2021-11-01)